DIL
AVXL icon

Deeter Investments LLP’s Anavex Life Sciences AVXL Stock Holding History

Deeter Investments LLP’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$99.3K Buy
+98,311
New +$602K 0.02% 101

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
NL
NWAM LLC Mercer Island, Washington $2B AUM 34.81% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Deeter Investments LLP's AVXL Position: Q4 2025 in Review

Deeter Investments LLP opened a new position in Anavex Life Sciences (AVXL) in Q4 2025: 98,311 shares worth $99.3K. The stake represents 0.02% of the portfolio and ranks #101 among its holdings.

184 funds tracked by Wall St. Rank hold AVXL as of Q4 2025.

  • Deeter Investments LLP held 98,311 shares of Anavex Life Sciences worth $99.3K as of Q4 2025.
  • Anavex Life Sciences was a new Deeter Investments LLP position in Q4 2025.
  • Anavex Life Sciences made up 0.02% of Deeter Investments LLP's portfolio in Q4 2025, its #101 holding.
  • 184 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q4 2025.

Based on Deeter Investments LLP's 13F filing for Q4 2025, filed 28 Aug 2026.